From August 30, 2023 to August 30, 2023, the company has repurchased 124,764 shares, representing 0.61% for KRW 299.43 million. With this, the company has completed the repurchase of 124,764 shares, representing 0.61% for KRW 299.43 million under the buyback announced on August 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,569 KRW | +1.29% | +10.18% | -38.83% |
1st Jan change | Capi. | |
---|---|---|
-38.83% | 38.04M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- A352770 Stock
- News Clinomics Inc.
- Tranche Update on Clinomics Inc.'s Equity Buyback Plan announced on August 30, 2023.